A M. Rauth - Publications
Affiliations: | University of Toronto, Toronto, ON, Canada |
Area:
Molecular Biology, BiochemistryYear | Citation | Score | |||
---|---|---|---|---|---|
2002 | Misra V, Klamut HJ, Rauth AM. Expression of the prodrug-activating enzyme DT-diaphorase via Ad5 delivery to human colon carcinoma cells in vitro. Cancer Gene Therapy. 9: 209-17. PMID 11857040 DOI: 10.1038/sj.cgt.7700430 | 0.435 | |||
2000 | Misra V, Grondin A, Klamut HJ, Rauth AM. Assessment of the relationship between genotypic status of a DT-diaphorase point mutation and enzymatic activity. British Journal of Cancer. 83: 998-1002. PMID 10993645 DOI: 10.1054/bjoc.2000.1359 | 0.45 | |||
1998 | Rauth AM, Melo T, Misra V. Bioreductive therapies: an overview of drugs and their mechanisms of action. International Journal of Radiation Oncology, Biology, Physics. 42: 755-62. PMID 9845091 DOI: 10.1016/S0360-3016(98)00302-2 | 0.424 | |||
1998 | Misra V, Klamut HJ, Rauth AM. Transfection of COS-1 cells with DT-diaphorase cDNA: role of a base change at position 609. British Journal of Cancer. 77: 1236-40. PMID 9579828 | 0.466 | |||
1997 | Rauth AM, Goldberg Z, Misra V. DT-diaphorase: possible roles in cancer chemotherapy and carcinogenesis. Oncology Research. 9: 339-49. PMID 9406240 | 0.466 | |||
1996 | Ross D, Traver RD, Siegel D, Kuehl BL, Misra V, Rauth AM. A polymorphism in NAD(P)H:quinone oxidoreductase (NQO1): relationship of a homozygous mutation at position 609 of the NQO1 cDNA to NQO1 activity. British Journal of Cancer. 74: 995-6. PMID 8826876 | 0.415 | |||
1995 | Kuehl BL, Paterson JW, Peacock JW, Paterson MC, Rauth AM. Presence of a heterozygous substitution and its relationship to DT-diaphorase activity. British Journal of Cancer. 72: 555-61. PMID 7669561 DOI: 10.1038/bjc.1995.373 | 0.309 | |||
Show low-probability matches. |